Can Biomarkers Identify Women at Increased Stroke Risk? The Women's Health Initiative Hormone Trials

• Charles Kooperberg ,

  *To whom correspondence should be addressed. E-mail: clk@fhcrc.org

  Affiliation Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• Mary Cushman,

  Affiliation College of Medicine, University of Vermont, Burlington, Vermont, United States of America

  ⨯
• Judith Hsia,

  Affiliation Department of Medicine, George Washington University, Washington, District of Columbia, United States of America

  ⨯
• Jennifer G Robinson,

  Affiliation Department of Medicine, University of Iowa, Iowa City, Iowa, United States of America

  ⨯
• Aaron K Aragaki,

  Affiliation Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• John K Lynch,

  Affiliation Stroke Neuroscience Unit, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, United States of America

  ⨯
• Alison E Baird,

  Affiliation Stroke Neuroscience Unit, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, United States of America

  ⨯
• Karen C Johnson,

  Affiliation Department of Preventive Medicine, University of Tennessee Health Sciences Center, Memphis, Tennessee, United States of America

  ⨯
• Lewis H Kuller,

  Affiliation Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Shirley A. A Beresford,

  Affiliation Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington, United States of America

  ⨯
• Beatriz Rodriguez

  Affiliation John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America

  ⨯